Advanced search
Publication Cover
Journal of Drug Targeting Volume 19, 2011 - Issue 5
Submit an article Journal homepage
154
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy

Yonghyun LeeCollege of Pharmacy, Pusan National University, Busan, Republic of Korea
,
In Ho KimCollege of Pharmacy, Pusan National University, Busan, Republic of Korea
,
Jeongyun KimCollege of Pharmacy, Pusan National University, Busan, Republic of Korea
,
Jeong-Hyun YoonCollege of Pharmacy, Pusan National University, Busan, Republic of Korea
,
Young Hee ShinCollege of Pharmacy, Kyungsung University, Busan, Republic of Korea
,
Yunjin JungCollege of Pharmacy, Pusan National University, Busan, Republic of KoreaCorrespondence[email protected] [email protected]
&
Young Mi KimCollege of Pharmacy, Pusan National University, Busan, Republic of Korea
 show all
Pages 336-343 | Received 01 Feb 2010, Accepted 31 May 2010, Published online: 08 Jul 2010

References

  • Andrew DM. (1992) Dextran prodrugs for colonic-specific drug delivery. In: Friend, D. R. (ed.) Oral colon specific drug delivery. CRC Press, Boca Raton, Fl, pp. 213–231.
  • Bruguerolle B, Labrecque G. (2007). Rhythmic pattern in pain and their chronotherapy. Adv Drug Deliv Rev, 59, 883–895.
  • Harboe E, Larsen C, Johansen M, Olesen HP. (1989). Macromolecular prodrugs. XV. Colon-targeted delivery–bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig. Pharm Res, 6, 919–923.
  • Jung YJ, Lee JS, Kim HH, Kim YT, Kim YM. (1998). Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid. Arch Pharm Res, 21, 179–186.
  • Kalala W, Kinget R, van den Mooter G, Samyn C. (1996). Colonic drug-targeting:in vitro release of ibuprofen from capsules coated with poly(ether-ester) azopolymers. Int J Pharmaceutics, 139, 187–195.
  • Kim H, Kong H, Choi B, Yang Y, Kim Y, Lim MJ, Neckers L, Jung Y. (2005). Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm Res, 22, 1499–1509.
  • Kinget R, Kalala W, Vervoort L, van den Mooter G. (1998). Colonic drug targeting. J Drug Target, 6, 129–149.
  • Larsen C, Harboe E, Johansen M, Olesen HP. (1989). Macromolecular prodrugs. XVI. Colon-targeted delivery–comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract. Pharm Res, 6, 995–999.
  • Larsen C, Jensen BH, Olesen HP. (1991). Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig. Acta Pharm Nord, 3, 71–76.
  • Lee JS, Jung YJ, Doh MJ, Kim YM. (2001). Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid. Drug Dev Ind Pharm, 27, 331–336.
  • McLeod AD, Friend DR, Tozer TN. (1993). Synthesis and chemical stability of glucocorticoid-dextran esters: potential prodrugs for colon-specific delivery. Int J Pharm, 92, 105–114.
  • McLeod AD, Friend DR, Tozer TN. (1994). Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. J Pharm Sci, 83, 1284–1288.
  • Nambu N, Kikuchi K, Kikuchi T, Takahashi Y, Ueda H, Nagai T. (1978). Influence of inclusion of nonsteroidal antiinflammatory drugs with beta-cyclodextrin on the irritation to stomach of rats upon oral administration. Chem Pharm Bull, 26, 3609–3612.
  • Nielsen LS, Weibel H, Johansen M, Larsen C. (1992). Macromolecular prodrugs. XX. Factors influencing model dextranase-mediated depolymerization of dextran derivatives in vitro. Acta Pharm Nord, 4, 23–30.
  • Sery TW, Hehre EJ. (1956). Degradation of dextrans by enzymes of intestinal bacteria. J Bacteriol, 71, 373–380.
  • Shen TY. (1983) Nonsteroidal anti-inflammatory agents. In: Wolff, M. E. (ed.) Burger’s Medicinal Chemistry. 4th edn. John Wiely & Sons, New York, pp. 1229–1233.
  • Sinha VR, Kumria R. (2001). Polysaccharides in colon-specific drug delivery. Int J Pharm, 224, 19–38.
  • Smolensky MH, Peppas NA. (2007). Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev, 59, 828–851.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.